Literature DB >> 10748621

Studies on antiplatelet agents from natural safrole. II. Synthesis and pharmacological properties of novel functionalized oxime O-benzylether derivatives.

A L Reis1, C B Ormelli, A L Miranda, C A Fraga, E J Barreiro.   

Abstract

In an ongoing research program aiming at the synthesis and pharmacological evaluation of new possible prototype candidates exploring the molecular hybridation and bioisosterism principles for molecular designing, we describe in this paper the design and synthesis of a series of new functionalized oxime O-benzylethers (4a-b) and (14a-b) as antiplatelet agents based on the inhibition of arachidonic acid (AA) cascade enzymes. For the synthesis of these new bioactive derivatives we used safrole (5), a Brazilian abundant natural product, as starting material. The platelet anti-aggregating evaluation of these oxime O-benzylether compounds (4a-b) and (14a-b) in model induced by ADP, collagen and AA, has permitted to evidence an antithrombotic profile to these new derivatives, being the most active the derivative methyl [[3,4-methylenedioxyphenyl]methylene]amino]oxy]-4-methylenephenylacet ic acid (14a).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10748621     DOI: 10.1016/s0031-6865(99)00014-x

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  1 in total

1.  Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.

Authors:  M A D Ferreira; N R F do Nascimento; C M de Sousa; O D L Pessoa; T L G de Lemos; J S Ventura; M Schattner; A M Chudzinski-Tavassi
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.